Answered You can hire a professional tutor to get the answer.
I need help creating a thesis and an outline on HIV/AIDS in Sub-Saharan Africa. Prepare this assignment according to the guidelines found in the APA Style Guide. An abstract is required.
I need help creating a thesis and an outline on HIV/AIDS in Sub-Saharan Africa. Prepare this assignment according to the guidelines found in the APA Style Guide. An abstract is required. Apart from pricing, other factors play their part in hampering the fight against HIV/AIDS. These are well noted by Calfee &. Bate (2004): “...In a fundamental sense, much of the criticism of drug pricing and related matters in treating HIV/AIDS in poor nations is misplaced. A rapid drop in prices, accompanied by a near-abandonment of intellectual property and the widespread availability of inexpensive generic drugs, has revealed that stumbling blocks in progress against HIV/AIDS in sub-Saharan Africa are not drug prices or patents. Rather, the barriers are inadequate healthcare infrastructures, an inability to administer drug therapy when it is needed and to avoid inappropriate drug therapy, the threat and reality of drug-resistant HIV strains, resistance to reasonable HIV therapy by governments, and severe administrative bottlenecks that have nothing to do with drug pricing or availability” (Calfee &. Bate 2004, p140-152).
For the fight against HIV/AIDS, access to antiretroviral medications is of prime importance. Until prevention and education programs are completely effective, A.R.V.s are needed to save lives, and the transnational pharmaceutical corporations can provide them. The major American manufacturers of A.R.V.s, Merck, Abbott, Bristol-Myers Squibb, Pfizer, and Glaxo Smith Kline, have dedicated millions of dollars to the fight against HIV/AIDS in developing nations (Angell 2004). The assistance has taken various forms: donating A.R.V.s, reducing their price to cost, investing in medical infrastructure and education programs, and voluntarily waiving patent rights so that generic, less costly versions of their drugs can be sold.
“The pharmaceutical industry is motivated by competitive and economic factors. From a competitive standpoint, research and development (R&.D) intensive .
